Dec 12 2024
Researchers from London Metropolitan University, Regent’s University London, and Imperial College London found that cannabis suppositories and online mindful compassion interventions significantly improved sexual function and reduced pain for women recovering from gynaecological cancer. The study, published in the journal Medicina, highlights the profound effect such treatments have on female sexuality and the limited research …
Dec 10 2024
A new systematic review and network meta-analysis, published in the Journal of Psychopharmacology, explores the potential of psychedelics to alleviate existential distress in terminally ill patients. Conducted by researchers from the University of Modena and Reggio Emilia, the Italy Department of Mental Health and Drug Abuse, and the University Utrecht in the Netherlands, the study …
Dec 09 2024
Psychedelics like LSD and psilocybin may improve sexual function for months after use, according to a study conducted by the Centre for Psychedelic Research at Imperial College London. This research marks the first known scientific investigation into the long-term effects of psychedelics on sexual health. Participants in the study reported significant improvements across various aspects …
Dec 05 2024
A randomized clinical trial conducted by researchers from the University of Washington, Fred Hutchinson Cancer Center, and the Yale School of Medicine has found that psilocybin therapy significantly reduces symptoms of depression in clinicians who developed moderate to severe symptoms while providing frontline care during the COVID-19 pandemic. The aim of the study was to …
Dec 05 2024
Clinical data published in the peer reviewed journal Medical Cannabis and Cannabinoids shows that a transdermal cannabinoid oil significantly reduces pain associated with diabetic peripheral neuropathy (DPN). The study, conducted at Don Chan Hospital in Thailand, involved 100 participants in a 12-week randomized, double-blind, placebo-controlled trial. Researchers evaluated the effects of a novel THC:CBD:CBN transdermal …
Dec 04 2024
According to the results of a new study using an animal model, CBD-rich cannabis oil “promotes social behavior by acting on oxytocin pathway”. The aim of the study, conducted by researchers at the University of Brescia and published in the December issue of Cannabis and Cannabinoid Research, “was to investigate the effect of a C. …
Dec 04 2024
A newly systematic review of clinical trials reveals psilocybin-assisted therapy may provide substantial relief for individuals with major depressive disorder, including treatment-resistant cases. Published in the psychiatry journal Acta Psychiatrica Scandinavica, the study consolidates findings from six randomized controlled trials, involving 427 participants, to evaluate the efficacy and safety of this emerging treatment. Researchers from …
Dec 01 2024
A new study published in the journal Pharmacology Biochemistry and Behavior shows that CBD may reverse the behavioral impairments associated with autism spectrum disorder. Researchers from the University of São Paulo and the Oswaldo Cruz Institute examined the effects of CBD on adult male mice exposed to valproic acid (VPA) during embryonic development, a model …
Dec 01 2024
Researchers from Suleyman Demirel University in Türkiye have published a study in the journal Reproductive Toxicology examining the potential of cannabidiol (CBD) to mitigate neuroinflammation and enhance neurogenesis in the offspring of pregnant rats subjected to systemic inflammation. The findings, available through the U.S. National Institute of Health, highlight the therapeutic potential of CBD during pregnancy …
Dec 01 2024
Psilocybin-assisted psychotherapy (PAP) has demonstrated promising outcomes in addressing multiple psychiatric symptoms in patients with cancer-related distress, according to a new study published in Nature Mental Health. Conducted by researchers from Johns Hopkins School of Medicine, Columbia University, New York University Grossman School of Medicine, and Yale University, the study analyzed data from two randomized, placebo-controlled …
